FDA Inspection
Dipnarine Maharaj, MDDipnarine Maharaj, MD – FDA Inspection, May 26, 2011
Record Details
This FDA Inspection record concerns Dipnarine Maharaj, MD, with an inspection on May 26, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Dipnarine Maharaj, MD
- Inspection Date
- May 26, 2011
- Product Type
- Biologics
View Company Profile
ID · 79ee42c0-ef39-42e4-a528-63aa50d27518
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 726421
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.56(a)Monitoring investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dipnarine Maharaj, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2018 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Dipnarine Maharaj, MD
- FDA Inspection 1055679 - 2018-06-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.